438 related articles for article (PubMed ID: 3086899)
1. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
2. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
[TBL] [Abstract][Full Text] [Related]
3. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
4. Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
Bidoggia H
Curr Med Res Opin; 1987; 10(9):601-11. PubMed ID: 3325229
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
6. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
9. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
10. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
11. Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.
Handler CE; Sullivan ID
Int J Cardiol; 1985 Feb; 7(2):149-57. PubMed ID: 3882583
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Quyyumi AA; Crake T; Wright CM; Mockus LJ; Fox KM
Br Heart J; 1987 Jun; 57(6):505-11. PubMed ID: 3304367
[TBL] [Abstract][Full Text] [Related]
13. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
[TBL] [Abstract][Full Text] [Related]
14. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
Marten W; Weiss M; Haase W
Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris.
Svendsen JH; Aldershvile J; Abildgaard U; Amtorp O
J Cardiovasc Pharmacol; 1989 Sep; 14(3):358-63. PubMed ID: 2476613
[TBL] [Abstract][Full Text] [Related]
16. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
Vogler AC; Silber S; Spiegelsberger F; Theisen K
Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
18. Dose-effect relationship amongst three different sustained-release forms of isosorbide 5-mononitrate in patients with coronary artery disease.
Kenedi P; Gathmann-Lewik U
Cardiology; 1987; 74 Suppl 1():29-33. PubMed ID: 3300975
[TBL] [Abstract][Full Text] [Related]
19. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris.
Emanuelsson H; Ake H; Kristi M; Arina R
Eur J Clin Pharmacol; 1989; 36(6):561-6. PubMed ID: 2506059
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study.
Liang CS; Coplin B; Wellington K
Am J Cardiol; 1985 May; 55(12):9E-14E. PubMed ID: 4003286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
